Team Europe is one of the lead contributors to COVAX, the global initiative to ensure fair and equitable access to COVID-19 vaccines.
Team Europe = the EU, EU member states and the EU financial institutions
A global solution to facilitate access to COVID-19 vaccines
What COVAX wants to provide
2 billion doses of COVID-19 vaccines, of which 1.3 billion doses reserved for low and middle income countries
20% of the population vaccinated in each country
- frontline healthcare workers
- most vulnerable groups
Which countries will receive the vaccine?
- 190 participating countries
- 92 low and middle income countries
Over 38 million doses of vaccines already delivered to 107 countries
Source: COVAX, up to 14 April 2021.
COVAX started delivering free vaccine doses on 24 February 2021, the first beneficiary country was Ghana.
Ghana:
First doses received: 24 February 2021
Doses received: 600 000 SII-AstraZeneca (COVISHIELD)
Doses allocated: 2 052 000
Honduras:
First doses received: 13 March 2021
Doses received: 48 000 AstraZeneca
Doses allocated: 424 800
Indonesia:
First doses received: 8 March 2021
Doses received: 1 113 600 AstraZeneca
Doses allocated: 11 704 800
Moldova:
First doses received: 4 March 2021
Doses received: 14 400 AstraZeneca
Doses allocated:
24 570 BioNTech-Pfizer
264 000 SII-AstraZeneca (COVISHIELD)
Afghanistan:
First doses received: 8 March 2021
Doses received: 468 000 SII-AstraZeneca (COVISHIELD)
Doses allocated: 2 580 000
Cambodia:
First doses received: 2 March 2021
Doses received: 324 000 SII-AstraZeneca (COVISHIELD)
Doses allocated: 1 104 000
Source: COVAX/GAVI, updated 22 March 2021.
Team Europe is one of the lead COVAX donors
- Team Europe €2.2 billion
- EU budget: €1 billion
- €400 million direct contribution
- €600 million in guarantees (together with European Investment Bank)
Source: COVAX/GAVI, 11 March 2021.
COVAX vaccine portfolio
- BioNTech-Pfizer
- AstraZeneca
- SII-AstraZeneca (COVISHIELD)*
- Johnson & Johnson
- SII-Novavax (COVOVAX)*
- Sanofi-GSK
*AstraZeneca/Novovax vaccines developed in partnership with the Serum Institute of India (SII).
Source: COVAX supply forecast (CEPI, Gavi, WHO), 7 April 2021.
The COVAX facility is a global initiative led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization, alongside key delivery partner UNICEF.
Text version
